Npj Vaccines impact factor, indexing, ranking (2024)


npj

Aim and Scope

The Npj Vaccines is a research journal that publishes research related to Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Nature Publishing Group. The ISSN of this journal is 20590105. Based on the Scopus data, the SCImago Journal Rank (SJR) of npj vaccines is 3.197.

Also, please check the following important details about npj vaccines: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Npj Vaccines Ranking

Impact Factor: 6.9
5-Year JIF: 6.7
SJR (SCImago Journal Rank): 3.197
Quartile: Q1

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Npj Vaccines is 6.9.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: npj Vaccines
Publisher: Nature Publishing Group
ISSN: 20590105
Type: journal
Journal Scope: Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
Country: United Kingdom
H-Index: 39
SJR: 3.197
Quartile: Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)

Indexing

The npj vaccines is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Npj Vaccines Impact Factor 2024

The latest impact factor of npj vaccines is 6.9 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Quartile

The latest Quartile of npj vaccines is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

According to journal website, the publication fee of npj vaccines is around 2790 GBP; 3490 USD; 3190 EUR.

The npj vaccines has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the npj vaccines publishes research articles in 11 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Npj Vaccines?

If your research is related to Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of npj vaccines and send your manuscript.

Tips for publishing in Npj Vaccines:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of npj vaccines is 6.9.
  • The npj vaccines is a reputed research journal.
  • It is published by Nature Publishing Group.
  • The journal is indexed in UGC CARE, Scopus, SCIE, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 3.197.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 11 weeks.
  • The Publication fee (APC) of npj vaccines 2790 GBP; 3490 USD; 3190 EUR.

Sources: https://www.nature.com/npjvaccines/







SIMILIAR JOURNALS


JOURNAL OF ANTIBIOTICS

ISSN: 0021-8820
Publisher: SPRINGERNATURE

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

ISSN: 0892-3973
Publisher: TAYLOR & FRANCIS LTD

REGULATORY TOXICOLOGY AND PHARMACOLOGY

ISSN: 0273-2300
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

FOOD AND AGRICULTURAL IMMUNOLOGY

ISSN: 0954-0105
Publisher: TAYLOR & FRANCIS LTD

INFLAMMOPHARMACOLOGY

ISSN: 0925-4692
Publisher: SPRINGER BASEL AG

INNATE IMMUNITY

ISSN: 1753-4259
Publisher: SAGE PUBLICATIONS LTD

BIOMARKERS

ISSN: 1354-750X
Publisher: TAYLOR & FRANCIS LTD

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

ISSN: 1386-1964
Publisher: ELSEVIER

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

ISSN: 1383-5718
Publisher: ELSEVIER

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

ISSN: 1383-5742
Publisher: ELSEVIER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.